A tender completed

Helios Underwriting (LSE:HUW) confirmed on 30 October 2026 that it had bought back 2,676,579 ordinary shares through its tender offer at 269p each, a total outlay of about £7.2m, with payment to shareholders expected around 3 November. The shares are being cancelled. The question worth asking is how this one-off distribution sits within the 24p per share of Capital the company said it expects to return during 2026, and what it signals about the board's view of surplus capital.

About Lloyd's capacity

In the Lloyd's market, syndicates underwrite insurance risks, and their capital comes from members who provide capacity, or the right to underwrite a share of a syndicate's business. Helios holds capacity across a range of syndicates, which spreads risk. The profit from each year of account is determined only after the year closes, usually after three years, when the results are final. That delay explains why profits and cash returns arrive in uneven amounts.

How Helios makes its money

LSE:HUW gives shareholders exposure to the Lloyd's insurance market by owning underwriting capacity on a spread of syndicates through Limited Liability vehicles. It supplies capital, earns a share of syndicate profits as each year of account closes, and can buy or sell capacity at Lloyd's auctions. That model means profits arrive in lumps, typically about three years after a year of account opens, which helps explain why cash returns tend to follow distributions from closed years.

Published on 29 September, profit before tax rose to £11.0m from £4.4m. Net asset value per share was £2.70, and the NAV total return was 17p per share, or 6.5%. The company received £40m of underwriting profits from the 2023 year of account and paid 10p per share in cash dividends.

Sizing the tender against the plan

The tender was announced alongside the interims and approved at a general meeting on 26 October. Its price of 269p represented a 17.7% premium to the previous day's closing price and was based on the half-year NAV. After the purchase, 73,363,432 shares remain in issue, of which 6,534,046 are held in treasury, leaving 66,829,386 voting shares.

On those figures, the tender amounts to roughly 10.4p for each voting share in issue beforehand. Added to the 10p of dividends already paid, that accounts for most of the 24p total the company has flagged, with any balance presumably coming through other Buybacks or dividends; the company's exact breakdown was not visible. Because the tender price sat close to reported NAV, it should neither materially dilute nor enhance NAV per share for continuing holders, while giving those who wanted to exit a route at near book value.

Why it matters

LSE:HUW linked the distribution to solid recent performance and favourable underwriting conditions at Lloyd's. Returning capital rather than buying more capacity is a choice in itself: it suggests management sees better value in shrinking the share base at around NAV than in paying up for additional syndicate participation. For an Investment company whose shares had traded below the tender price, it also offered a mechanism to narrow any gap between Market Value and NAV.

Risks and limits

Future returns depend on the outcome of open years of account, which are exposed to catastrophe losses, reserve movements and the softening rate environment the market has been discussing. A smaller share count concentrates both upside and downside on remaining shareholders. The capital withdrawn also cannot support future capacity growth.

The tender arithmetic

The price of 269p compared with a net asset value of £2.70 per share, so the tender was priced at a very slight discount to NAV of about 0.4%. The premium of 17.7% to the previous close implies a close of about 228.5p, so the Market Price was about 15% below NAV before the tender. For shareholders who tendered, the offer provided a price much closer to NAV than the market did. For those who did not, the reduction in the share count increases each remaining share's claim on the company's assets, though only marginally, since the price was close to NAV.

The 2,676,579 shares bought were about 3.5% of the 73,363,432 plus 2,676,579, or 76,040,011 shares in issue before the tender, so the tender removed a small proportion of the capital.

Profit and returns

Profit before tax of £11.0m against £4.4m is a rise of 150%. The NAV total return of 17p, or 6.5%, combines the increase in NAV and the dividends paid. The £40m received from the 2023 year of account is large relative to the tender cost of £7.2m, so the cash returned to shareholders is a fraction of the underwriting profits received.

Treasury shares

Of the 73,363,432 shares in issue after the tender, 6,534,046 are held in treasury, about 8.9%. Treasury shares do not carry voting rights, so the voting total of 66,829,386 is the relevant figure for shareholders' notifications. Holding shares in treasury allows a company to reissue them later, whereas cancelling them removes them permanently, which is what is being done with the shares bought in the tender.

The choice between capacity and returns

Buying capacity at Lloyd's auctions means paying for the right to underwrite in future years, which can raise profits if underwriting is successful. Choosing to return capital suggests the board considers the price of capacity less attractive than buying in its own shares at about NAV. The reverse can also be true in other periods, which is why the capacity decision is reviewed each year.

Timing of Lloyd's profits

Because profit on a Lloyd's year of account is determined after about three years, the results the company reports in one year reflect underwriting decisions made earlier. Catastrophe losses, claims Inflation and Reinsurance costs all feed into the final result. The amounts received in cash from closed years then determine what can be returned to shareholders.

What comes next

Management said it expects NAV to rise as pipeline profits are recognised and anticipates solid returns from the 2024 year of account, which is due to close at the end of 2026. Full-year results for 2026 would be the next major disclosure, although no date was found. Investors will watch whether the board repeats a tender in 2027 or reverts to buybacks, and whether year-end NAV confirms the half-year figure behind the tender.